Daily Rapid Antigen Exit Testing to Tailor University COVID-19 Isolation Policy
- PMID: 36417936
- PMCID: PMC9707582
- DOI: 10.3201/eid2812.220969
Daily Rapid Antigen Exit Testing to Tailor University COVID-19 Isolation Policy
Abstract
We evaluated daily rapid antigen test (RAT) data from 323 COVID-19-positive university students in Connecticut, USA, during an Omicron-dominant period. Day 5 positivity was 47% for twice-weekly screeners and 26%-28% for less-frequent screeners, approximately halving each subsequent day. Testing negative >10 days before diagnosis (event time ratio (ETR) 0.85 [95% CI 0.75-0.96]) and prior infection >90 days (ETR 0.50 [95% CI 0.33-0.76]) were significantly associated with shorter RAT positivity duration. Symptoms before or at diagnosis (ETR 1.13 [95% CI 1.02-1.25]) and receipt of 3 vaccine doses (ETR 1.20 [95% CI 1.04-1.39]) were significantly associated with prolonged positivity. Exit RATs enabled 53%-74% of students to leave isolation early when they began isolation at the time of the first positive test, but 15%-22% remained positive beyond the recommended isolation period. Factors associated with RAT positivity duration should be further explored to determine relationships with infection duration.
Keywords: COVID-19; SARS-CoV-2; United States; coronavirus disease; direct-to-consumer screening and testing; epidemiology; patient isolation; respiratory infections; severe acute respiratory syndrome coronavirus 2; student health services; viruses; zoonoses.
Figures

References
-
- Centers for Disease Control and Prevention. Isolation and precautions for people with COVID-19. 2022. [cited 2022 Feb 16]. https://www.cdc.gov/coronavirus/2019-ncov/if-you-are-sick/quarantine-iso...
-
- Lambrou AS, Shirk P, Steele MK, Paul P, Paden CR, Cadwell B, et al. ; Strain Surveillance and Emerging Variants Bioinformatic Working Group; Strain Surveillance and Emerging Variants NS3 Working Group. Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants - United States, June 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022;71:206–11. 10.15585/mmwr.mm7106a4 - DOI - PMC - PubMed
-
- Lefferts B, Blake I, Bruden D, Hagen MB, Hodges E, Kirking HL, et al. Antigen test positivity after COVID-19 isolation—Yukon-Kuskokwim Delta region, Alaska, January–February 2022. [cited 2022 Feb 25]. MMWR Morb Mortal Wkly Rep. 2022;71:293–8 https://www.cdc.gov/mmwr/volumes/71/wr/mm7108a3.htm. 10.15585/mmwr.mm7108a3 - DOI - PubMed
-
- Centers for Disease Control and Prevention. Ending isolation and precautions for people with COVID-19: interim guidance. 2022. [cited 2022 Mar 2]. https://www.cdc.gov/coronavirus/2019-ncov/hcp/duration-isolation.html
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous